AdvisorShares Pure US Cannabis ETF (MSOS) - Stock Analysis
Last updated: Apr 29, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Cannabis policy catalyst plus momentum: federal marijuana restrictions are easing, rescheduling activity could reduce 280E tax pressure for operators, cannabis ETFs have been among top performers, and MSOS is up about 36% over 21 trading days.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Description
This actively managed ETF invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of U.S. companies that derive at least 50% of their net revenue from marijuana and hemp, as well as derivatives that provide similar economic exposure. It will concentrate at least 25% of its holdings in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 29 | May 6 | MSOS | AdvisorShares Pure US Cannabis ETF | Cannabis policy catalyst plus momentum: federal marijuana restrictions are easing, rescheduling activity could reduce 280E tax pressure for operators, cannabis ETFs have been among top performers, and MSOS is up about 36% over 21 trading days. | Closed | +8.9% |
| Dec 18 | Dec 25 | MSOS | AdvisorShares Pure US Cannabis ETF | Exceptional short-term price surge nearly doubling in one week on regulatory optimism regarding U.S. marijuana reclassification. Strong investor demand and breakout technical patterns support a hot idea for near-term tactical gains, though elevated volatility and sector concentration warrant cautious position sizing. | Closed | -2.9% |